CW June 2004Issue Number 6 June 2004 ISSN 10593802 Selective Enzyme Inhibitor Prevents Esophageal CancerNitric oxide, a small endogenous molecule that is produced from an amino acid by an enzyme is thought to be associated in cancer development. A selective inhibitor of this enzyme prevents chemically-induced esophageal cancer in animal models. Because the nitric oxide synthesizing enzyme is overexpressed in some human cancers, the inhibitors of this enzyme might also be useful in preventing human cancer.
Go to Previous Page Go to Next Page Source & Additional Reading Chen et al., Cancer Research, May 15, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |